Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
With a market cap of 65.17B, Regeneron(REGN) trades at $621.52. The stock has a price-to-earnings ratio of 15.29 and currently yields dividends of 57.0%.
As of 2026-05-28, Regeneron(REGN) stock has fluctuated between $620.35 and $635.00. The current price stands at $621.52, placing the stock +0.2% above today's low and -2.1% off the high.
Regeneron(REGN) shares are trading with a volume of 1.19M, against a daily average of 1.3M.
In the last year, Regeneron(REGN) shares hit a 52-week high of $821.11 and a 52-week low of $476.49.
In the last year, Regeneron(REGN) shares hit a 52-week high of $821.11 and a 52-week low of $476.49.
REGN News
...
Technology Why Apogee Slipped On Its Dupixent-Rivaling Eczema Results Licensing Apogee Therapeutics (APGE) reported mixed results for its experimental eczema tr...
Regeneron Pharmaceuticals (REGN) is back in focus after three pipeline updates in quick succession, including early Lynozyfic data in systemic AL amyloidosis, a...
Analyst ratings
74%
of 31 ratingsMore REGN News
Earlier in May 2026, Regeneron Pharmaceuticals reported that its Phase 3 trial of fianlimab plus cemiplimab in first-line metastatic melanoma did not reach stat...
Analysts are intrested in these 5 stocks: ( (REGN) ), ( (CRCL) ), ( (BURL) ), ( (ROST) ) and ( (PBA) ). Here is a breakdown of their recent ratings and the rati...
Regeneron Pharmaceuticals (NasdaqGS:REGN) reported positive Phase 1/2 data for Lynozyfic (linvoseltamab) in systemic AL amyloidosis, with all patients achieving...
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intel...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.